谷歌浏览器插件
订阅小程序
在清言上使用

Not just an anti-eosinophil drug: tezepelumab treatment for type 2 asthma and beyond

The European respiratory journal(2023)

引用 1|浏览48
暂无评分
摘要
Tezepelumab, a biologic therapy for severe asthma, blocks TSLP activity, subsequently downregulating multiple type 2 inflammatory pathways and reducing airway hyperresponsiveness via eosinophil-independent effects https://bit.ly/3XGpaV3
更多
查看译文
关键词
tezepelumab treatment,asthma,anti-eosinophil
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要